India’s Central Drugs Standard Control Organisation (CDSCO) has released new guidelines that allow the compounding of minor drug-related violations, marking a significant step toward faster enforcement, improved compliance, and reduced litigation within the pharmaceutical ecosystem. The guidelines outline specific categories of procedural and technical lapses that